2. Healthcare
  3. Drug based on CAR T-Cell Market
request_sample_pdf Download FREE Sample

Drug based on CAR T-Cell Market Size, Share, Growth, and Industry Analysis, By Types (CD19-targeted,BCMA-targeted), By Applications (Lymphoma,Multiple Myeloma) , and Regional Insights and Forecast to 2035

Animal Feed Testing Market Report
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drug based on CAR T-Cell Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug based on CAR T-Cell Market Perspective (2020-2031)
2.2 Global Drug based on CAR T-Cell Growth Trends by Region
2.2.1 Global Drug based on CAR T-Cell Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug based on CAR T-Cell Historic Market Size by Region (2020-2025)
2.2.3 Drug based on CAR T-Cell Forecasted Market Size by Region (2026-2031)
2.3 Drug based on CAR T-Cell Market Dynamics
2.3.1 Drug based on CAR T-Cell Industry Trends
2.3.2 Drug based on CAR T-Cell Market Drivers
2.3.3 Drug based on CAR T-Cell Market Challenges
2.3.4 Drug based on CAR T-Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug based on CAR T-Cell Players by Revenue
3.1.1 Global Top Drug based on CAR T-Cell Players by Revenue (2020-2025)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2020-2025)
3.2 Global Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug based on CAR T-Cell Revenue
3.4 Global Drug based on CAR T-Cell Market Concentration Ratio
3.4.1 Global Drug based on CAR T-Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug based on CAR T-Cell Revenue in 2024
3.5 Global Key Players of Drug based on CAR T-Cell Head office and Area Served
3.6 Global Key Players of Drug based on CAR T-Cell, Product and Application
3.7 Global Key Players of Drug based on CAR T-Cell, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug based on CAR T-Cell Breakdown Data by Type
4.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2020-2025)
4.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2026-2031)
5 Drug based on CAR T-Cell Breakdown Data by Application
5.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2020-2025)
5.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug based on CAR T-Cell Market Size (2020-2031)
6.2 North America Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug based on CAR T-Cell Market Size by Country (2020-2025)
6.4 North America Drug based on CAR T-Cell Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size (2020-2031)
7.2 Europe Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug based on CAR T-Cell Market Size by Country (2020-2025)
7.4 Europe Drug based on CAR T-Cell Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug based on CAR T-Cell Market Size (2020-2031)
8.2 Asia-Pacific Drug based on CAR T-Cell Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug based on CAR T-Cell Market Size (2020-2031)
9.2 Latin America Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug based on CAR T-Cell Market Size by Country (2020-2025)
9.4 Latin America Drug based on CAR T-Cell Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug based on CAR T-Cell Market Size (2020-2031)
10.2 Middle East & Africa Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug based on CAR T-Cell Introduction
11.1.4 Novartis Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drug based on CAR T-Cell Introduction
11.2.4 Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Drug based on CAR T-Cell Introduction
11.4.4 J & J Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drug based on CAR T-Cell Introduction
11.5.4 JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drug based on CAR T-Cell Introduction
11.6.4 FOSUNKite Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Details
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Introduction
11.8.4 CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Details
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Introduction
11.9.4 Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Details
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Introduction
11.10.4 Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Details
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio Drug based on CAR T-Cell Introduction
11.11.4 Mustang Bio Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Details
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio Drug based on CAR T-Cell Introduction
11.12.4 Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Details
11.13.2 Cellectis Business Overview
11.13.3 Cellectis Drug based on CAR T-Cell Introduction
11.13.4 Cellectis Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Details
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Introduction
11.14.4 Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Details
11.15.2 Celyad Business Overview
11.15.3 Celyad Drug based on CAR T-Cell Introduction
11.15.4 Celyad Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

;